iifl-logo-icon 1

Dr Agarwals Eye Hospital Ltd Share Price

3,399.75
(0.53%)
Jul 22, 2024|02:38:00 PM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open3,400
  • Day's High3,500
  • 52 Wk High3,660
  • Prev. Close3,381.8
  • Day's Low3,330.05
  • 52 Wk Low1,370
  • Turnover (lac)43.61
  • P/E34.28
  • Face Value10
  • Book Value334.36
  • EPS98.64
  • Mkt. Cap (Cr.)1,597.88
  • Div. Yield0.07
No Records Found

Dr Agarwals Eye Hospital Ltd KEY RATIOS

Sector

Healthcare

Open

3,400

Prev. Close

3,381.8

Turnover(Lac.)

43.61

Day's High

3,500

Day's Low

3,330.05

52 Week's High

3,660

52 Week's Low

1,370

Book Value

334.36

Face Value

10

Mkt Cap (₹ Cr.)

1,597.88

P/E

34.28

EPS

98.64

Divi. Yield

0.07

Dr Agarwals Eye Hospital Ltd Corporate Action

18 Apr 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

20 Oct 2023

12:00 AM

Dividend

Dividend Amount: 2.5

Record Date: 31 Oct, 2023

arrow

30 Aug 2023

12:00 AM

BookCloser

arrow

30 Aug 2023

12:00 AM

AGM

Announcement Date: 30 Aug, 2023

arrow

Dr Agarwals Eye Hospital Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Dr Agarwals Eye Hospital Ltd SHAREHOLDING SNAPSHOT

22 Jul, 2024|02:46 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 71.89%

Foreign: 0.00%

Indian: 71.89%

Non-Promoter- 0.64%

Institutions: 0.64%

Non-Institutions: 27.45%

Custodian: 0.00%

Share Price

Dr Agarwals Eye Hospital Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

4.7

4.7

4.7

4.7

Preference Capital

0

0

0

0

Reserves

108.64

73.47

49.96

51.4

Net Worth

113.34

78.17

54.66

56.1

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

139.8

175.95

153.32

148.54

yoy growth (%)

-20.54

14.76

3.21

8.77

Raw materials

-16.24

-22.03

-18.14

-18.24

As % of sales

11.62

12.52

11.83

12.28

Employee costs

-32.17

-35.63

-31.98

-32.49

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

5.73

19.94

13.36

10.97

Depreciation

-19.09

-21.23

-9.78

-8.74

Tax paid

-7.17

-6.25

-6.58

-3.63

Working capital

6.02

9.68

-3.86

1.56

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

-20.54

14.76

3.21

8.77

Op profit growth

-34.29

97.25

9.52

26.34

EBIT growth

-56.28

73.25

11.48

64.71

Net profit growth

-110.51

101.96

-7.67

19,895.36

View Ratios

No Record found

Dr Agarwals Eye Hospital Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Apollo Hospitals Enterprise Ltd

APOLLOHOSP

6,385

90.8591,806.5238.80.091,894.6536.28

Max Healthcare Institute Ltd

MAXHEALTH

920.05

130.1389,420.8241.770.16610.1179.02

Fortis Healthcare Ltd

FORTIS

480.8

293.1736,298.3968.330.21307.48120.36

Global Health Ltd

MEDANTA

1,202.5

89.6132,288.0192.240578.65106.09

Narayana Hrudayalaya Ltd

NH

1,242

59.825,381.61158.090.32846.3190.04

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Dr Agarwals Eye Hospital Ltd

Management

Register Office

Registrar Office

Chairman / Executive Director / M D / Promoter

Amar Agarwal.

WTD & Executive Director

Athiya Agarwal

Independent Non Exe. Director

Sanjay Anand

Non Executive Director

Adil Agarwal

Independent Non Exe. Director

Lakshmmi Subramanian

Independent Non Exe. Director

V Balakrishnan

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Founded in 1957, Dr. Agarwals Eye Hospital Limited was incorporated on April 22, 1994. The Hospital is a leading chain of eye hospitals with predominant presence in Tamil Nadu. Under the able leadership of Dr Amar Agarwal, the Company has been a pioneer and leader in the Indian Ophthalmology market with an established market position, healthy brand recall in the eye care segment. It offers comprehensive services in the eye-care segment including Cataract, Glaucoma, Laser Correction, Cornea and Refractive, Retina, and Squint among others. It has presence in multiple locations in Tamil Nadu, Kerala and Rajasthan. Till 30 Sep.94 the eye care facility was provided by the family through various partnership firms owned by the family members. Since Oct.94, the entire hospital business is carried on by the company. As such, it has the distinct advantage of capitalising on the reputation built by the Agarwals over a period of 37 years and aim at further growth by carrying out immediate expansion.In 1995-96, the company commenced commercial production of pharmaceutical products in a limited way.During 1996-97, it installed Lasik Excimer Laser which is of its only kind in India and the company has been constantly striving to update the surgical techniques by adopting innovative methods and by employing the latest equipments both for Surgery and Research.During 2004, the Hospital started their Jaipur branch. It opened a Medical Enclave at Nungambakkam, Chennai and a Franchisee Centre at
Read More

Company FAQs

What is the Dr Agarwals Eye Hospital Ltd share price today?

Down Arrow

The Dr Agarwals Eye Hospital Ltd shares price on BOMBAY STOCK EXCHANGE (BSE) is Rs.₹3399.75 today.

What is the Market Cap of Dr Agarwals Eye Hospital Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Dr Agarwals Eye Hospital Ltd is ₹1597.88 Cr. as of 22 Jul ‘24

What is the PE and PB ratio of Dr Agarwals Eye Hospital Ltd?

Down Arrow

The PE and PB ratios of Dr Agarwals Eye Hospital Ltd is 34.28 and 10.11 as of 22 Jul ‘24

What is the 52 Week High and Low of Dr Agarwals Eye Hospital Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Dr Agarwals Eye Hospital Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Dr Agarwals Eye Hospital Ltd is ₹1370 and ₹3660 as of 22 Jul ‘24

What is the CAGR of Dr Agarwals Eye Hospital Ltd?

Down Arrow

Dr Agarwals Eye Hospital Ltd's CAGR for 5 Years at 66.41%, 3 Years at 95.28%, 1 Year at 138.06%, 6 Month at 11.28%, 3 Month at 3.04% and 1 Month at 9.97%.

What is the shareholding pattern of Dr Agarwals Eye Hospital Ltd?

Down Arrow

The shareholding pattern of Dr Agarwals Eye Hospital Ltd is as follows:
Promoters - 71.90 %
Institutions - 0.65 %
Public - 27.46 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.